Corteva To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 14 2025
0mins
Should l Buy CTVA?
Source: Benzinga
Analyst Rating Changes: Several Wall Street analysts have adjusted their price targets and ratings for various companies, including cuts for Winnebago, Celanese, Comcast, Cricut, and Flywire, while Fastenal and Choice Hotels received upgrades.
Current Stock Performance: The closing prices of the affected stocks show a mix of performance, with some stocks trading below their new price targets, indicating potential investor sentiment shifts following these analyst changes.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CTVA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CTVA
Wall Street analysts forecast CTVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CTVA is 79.17 USD with a low forecast of 68.00 USD and a high forecast of 86.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Analyst Rating
10 Buy
2 Hold
0 Sell
Strong Buy
Current: 75.040
Low
68.00
Averages
79.17
High
86.00
Current: 75.040
Low
68.00
Averages
79.17
High
86.00
About CTVA
Corteva, Inc. is a global pure-play agriculture company. It is a global provider of seed and crop protection solutions focused on the agriculture industry and contributing to a healthier, secure and sustainable food supply. The Seed segment is engaged in developing and supplying commercial seed combining advanced germplasm and traits that produce optimum yield for farms around the world. It operates in various key seed markets, including North American corn and soybeans, European corn and sunflower, as well as Brazil, India, South Africa and Argentina corn. The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that support overall crop health both above and below ground via nitrogen management and seed-applied technologies. Its crop protection solutions and digital solutions provide farmers with tools to improve productivity and help keep fields free of weeds, insects and diseases.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Corteva Q4 2025 Earnings Call Insights
- Separation Progress: CEO Charles Magro highlighted that Corteva is on track for a separation in Q4 2025, with announcements for a new CEO and SpinCo brand identity expected in the first half, laying a strategic foundation for future growth.
- Impact of Bayer Agreement: The comprehensive resolution with Bayer is projected to generate about $1 billion in earnings upside over the next decade, allowing SpinCo to focus on value creation opportunities while reducing uncertainties from ongoing litigation.
- Financial Performance Highlights: Despite a 4% year-over-year decline in organic sales for Q4, the company achieved a 4% growth in annual organic sales, with operating EBITDA reaching $3.85 billion and EBITDA margins exceeding 22% for the first time, showcasing significant improvements in cost control and profitability.
- 2026 Outlook: Corteva reiterated its 2026 operating EBITDA guidance at a midpoint of $4.1 billion, expecting approximately 7% growth, while planning to repurchase about $500 million in shares in the first half, further enhancing shareholder returns.
See More
Multiple Companies Show Poor After-Hours Trading Performance
- Chipotle Traffic Decline: Chipotle reported a fourth consecutive quarter of declining restaurant traffic, leading to a 6% drop in stock price and projecting flat same-store sales growth for 2026, which could hinder its market competitiveness and future growth potential.
- Corteva Sales Miss: Corteva's stock fell 5% after reporting a fourth-quarter sales miss, impacted by falling crop prices and geopolitical tensions, which may lead to weakened demand and affect the company's performance going forward.
- AMD Revenue Guidance Below Analysts: AMD shares declined about 7% as it projected first-quarter revenue at $9.8 billion, below analysts' expectations of $9.38 billion, although its non-GAAP gross margin aligned with market estimates, potentially affecting investor confidence.
- Enphase Energy Strong Guidance: Enphase Energy's stock jumped about 19% as it issued a revenue guidance range of $270 million to $300 million for the first quarter, exceeding market expectations, indicating robust growth potential in the renewable energy sector.
See More
Corteva's Q4 Results Miss Revenue Expectations
- Performance Overview: Corteva (CTVA) reported adjusted earnings per share of $0.22 for Q4, meeting expectations, but revenue of $3.91 billion fell short of Wall Street's $4.23 billion forecast, resulting in a 5.7% drop in after-hours trading.
- Deepening Net Loss: The company's net loss widened to $537 million, or $0.80 per share, significantly increasing from a $50 million loss a year earlier, reflecting pressures from market competition and rising costs.
- Sales and Delivery Issues: Total volume in seed and crop protection declined by 5% year-over-year, with seed net sales down 2% to $1.74 billion, partly due to North American deliveries being pushed to Q1 2026 due to weather and freight optimization, impacting overall performance.
- Future Outlook: Corteva expects operating earnings to reach between $4.0 billion and $4.2 billion in 2026 and plans to complete its separation in the second half of 2026, despite anticipating a $610 million cash outflow, demonstrating the company's commitment to strategic adjustments.
See More
Corteva Releases 2026 Financial Outlook
- Earnings Report: Corteva reported a Q4 non-GAAP EPS of $0.22, meeting expectations, but revenue of $3.91 billion fell short by $320 million, reflecting a 1.8% year-over-year decline and indicating signs of weak market demand.
- Future Outlook: The company anticipates operating EBITDA for 2026 to range between $4.0 billion and $4.2 billion, suggesting a 7% growth at the midpoint, which indicates Corteva's optimistic stance on future profitability despite current challenges.
- EPS Projections: Corteva expects its EPS for 2026 to be between $3.45 and $3.70, also reflecting a 7% growth at the midpoint, showcasing the company's ongoing efforts to enhance profitability amid an uncertain market environment.
- Stock Price Reaction: Following the earnings release, Corteva's shares fell by 1%, indicating investor reaction to the missed revenue expectations, which could impact future investor confidence in the company.
See More
Corteva Reports 2025 Financial Results: Sales Growth and Separation Progress
- Sales Performance Overview: In Q4 2025, Corteva reported net sales of $3.91 billion, a 2% decline year-over-year, primarily due to seasonal delivery delays in Crop Protection and Seed, although full-year sales reached $17.40 billion, reflecting a 3% increase, demonstrating resilience in the market.
- Profitability Analysis: The GAAP loss from continuing operations in Q4 was $537 million, significantly higher than the $50 million loss in Q4 2024, indicating challenges in cost control and market competition, despite an annual operating EBITDA of $4.0 billion, showcasing overall profitability improvement.
- Seed Business Performance: Seed net sales for Q4 2025 were $1.74 billion, down 2% year-over-year, mainly due to seasonal delays in North American deliveries; however, full-year seed sales reached $9.90 billion, up 4%, indicating strong demand for premium technology.
- Separation Progress and Future Outlook: Corteva plans to complete its separation from Bayer in the second half of 2026, which is expected to enhance its operational freedom in the agricultural market, with management optimistic about growth in 2026, projecting a 7% increase in operating EBITDA.
See More
Corteva Reports 2025 Financial Results and Growth Outlook for 2026
- Strong Financial Performance: Corteva's net sales for FY 2025 reached $17.40 billion, a 3% increase year-over-year, with seed business net sales growing by 4%, reflecting robust demand for new technologies and licensing growth, which is expected to further drive revenue in the future.
- Robust Cash Flow: The company generated $2.9 billion in free cash flow for 2025, a 69% improvement over the previous year, providing strong support for future investments and shareholder returns, showcasing effective working capital management.
- Separation Plan Progress: Corteva is on track to complete its planned separation in the second half of 2026, with key milestones expected in the first half of 2026, including the appointment of a new CEO and the launch of brand identity, laying the groundwork for future independent operations.
- Bayer Settlement Accelerates Innovation: The comprehensive resolution with Bayer ensures clarity on technology access and licensing rights, expected to accelerate Corteva's innovation in seed technology, aiming for a $1 billion net royalty income by 2035, further enhancing its competitive position in the market.
See More
Corteva Q4 2025 Earnings Call Insights
- Separation Progress: CEO Charles Magro highlighted that Corteva is on track for a separation in Q4 2025, with announcements for a new CEO and SpinCo brand identity expected in the first half, laying a strategic foundation for future growth.
- Impact of Bayer Agreement: The comprehensive resolution with Bayer is projected to generate about $1 billion in earnings upside over the next decade, allowing SpinCo to focus on value creation opportunities while reducing uncertainties from ongoing litigation.
- Financial Performance Highlights: Despite a 4% year-over-year decline in organic sales for Q4, the company achieved a 4% growth in annual organic sales, with operating EBITDA reaching $3.85 billion and EBITDA margins exceeding 22% for the first time, showcasing significant improvements in cost control and profitability.
- 2026 Outlook: Corteva reiterated its 2026 operating EBITDA guidance at a midpoint of $4.1 billion, expecting approximately 7% growth, while planning to repurchase about $500 million in shares in the first half, further enhancing shareholder returns.
See More
Multiple Companies Show Poor After-Hours Trading Performance
- Chipotle Traffic Decline: Chipotle reported a fourth consecutive quarter of declining restaurant traffic, leading to a 6% drop in stock price and projecting flat same-store sales growth for 2026, which could hinder its market competitiveness and future growth potential.
- Corteva Sales Miss: Corteva's stock fell 5% after reporting a fourth-quarter sales miss, impacted by falling crop prices and geopolitical tensions, which may lead to weakened demand and affect the company's performance going forward.
- AMD Revenue Guidance Below Analysts: AMD shares declined about 7% as it projected first-quarter revenue at $9.8 billion, below analysts' expectations of $9.38 billion, although its non-GAAP gross margin aligned with market estimates, potentially affecting investor confidence.
- Enphase Energy Strong Guidance: Enphase Energy's stock jumped about 19% as it issued a revenue guidance range of $270 million to $300 million for the first quarter, exceeding market expectations, indicating robust growth potential in the renewable energy sector.
See More
Corteva's Q4 Results Miss Revenue Expectations
- Performance Overview: Corteva (CTVA) reported adjusted earnings per share of $0.22 for Q4, meeting expectations, but revenue of $3.91 billion fell short of Wall Street's $4.23 billion forecast, resulting in a 5.7% drop in after-hours trading.
- Deepening Net Loss: The company's net loss widened to $537 million, or $0.80 per share, significantly increasing from a $50 million loss a year earlier, reflecting pressures from market competition and rising costs.
- Sales and Delivery Issues: Total volume in seed and crop protection declined by 5% year-over-year, with seed net sales down 2% to $1.74 billion, partly due to North American deliveries being pushed to Q1 2026 due to weather and freight optimization, impacting overall performance.
- Future Outlook: Corteva expects operating earnings to reach between $4.0 billion and $4.2 billion in 2026 and plans to complete its separation in the second half of 2026, despite anticipating a $610 million cash outflow, demonstrating the company's commitment to strategic adjustments.
See More
Corteva Releases 2026 Financial Outlook
- Earnings Report: Corteva reported a Q4 non-GAAP EPS of $0.22, meeting expectations, but revenue of $3.91 billion fell short by $320 million, reflecting a 1.8% year-over-year decline and indicating signs of weak market demand.
- Future Outlook: The company anticipates operating EBITDA for 2026 to range between $4.0 billion and $4.2 billion, suggesting a 7% growth at the midpoint, which indicates Corteva's optimistic stance on future profitability despite current challenges.
- EPS Projections: Corteva expects its EPS for 2026 to be between $3.45 and $3.70, also reflecting a 7% growth at the midpoint, showcasing the company's ongoing efforts to enhance profitability amid an uncertain market environment.
- Stock Price Reaction: Following the earnings release, Corteva's shares fell by 1%, indicating investor reaction to the missed revenue expectations, which could impact future investor confidence in the company.
See More
Corteva Reports 2025 Financial Results: Sales Growth and Separation Progress
- Sales Performance Overview: In Q4 2025, Corteva reported net sales of $3.91 billion, a 2% decline year-over-year, primarily due to seasonal delivery delays in Crop Protection and Seed, although full-year sales reached $17.40 billion, reflecting a 3% increase, demonstrating resilience in the market.
- Profitability Analysis: The GAAP loss from continuing operations in Q4 was $537 million, significantly higher than the $50 million loss in Q4 2024, indicating challenges in cost control and market competition, despite an annual operating EBITDA of $4.0 billion, showcasing overall profitability improvement.
- Seed Business Performance: Seed net sales for Q4 2025 were $1.74 billion, down 2% year-over-year, mainly due to seasonal delays in North American deliveries; however, full-year seed sales reached $9.90 billion, up 4%, indicating strong demand for premium technology.
- Separation Progress and Future Outlook: Corteva plans to complete its separation from Bayer in the second half of 2026, which is expected to enhance its operational freedom in the agricultural market, with management optimistic about growth in 2026, projecting a 7% increase in operating EBITDA.
See More
Corteva Reports 2025 Financial Results and Growth Outlook for 2026
- Strong Financial Performance: Corteva's net sales for FY 2025 reached $17.40 billion, a 3% increase year-over-year, with seed business net sales growing by 4%, reflecting robust demand for new technologies and licensing growth, which is expected to further drive revenue in the future.
- Robust Cash Flow: The company generated $2.9 billion in free cash flow for 2025, a 69% improvement over the previous year, providing strong support for future investments and shareholder returns, showcasing effective working capital management.
- Separation Plan Progress: Corteva is on track to complete its planned separation in the second half of 2026, with key milestones expected in the first half of 2026, including the appointment of a new CEO and the launch of brand identity, laying the groundwork for future independent operations.
- Bayer Settlement Accelerates Innovation: The comprehensive resolution with Bayer ensures clarity on technology access and licensing rights, expected to accelerate Corteva's innovation in seed technology, aiming for a $1 billion net royalty income by 2035, further enhancing its competitive position in the market.
See More
